New Johnson & Johnson data shows second shot boosts antibodies and protection against COVID-19 – but one dose is still strong against delta variant

Your body produces antibodies after an infection or vaccine, but these slowly decline over time. New Johnson & Johnson data sheds light on the duration of protection and the need for booster shots.

Maureen Ferran, Associate Professor of Biology, Rochester Institute of Technology • conversation
Sept. 25, 2021 ~8 min

Tense decision-making as CDC joins FDA in recommending Pfizer booster shot for 65 & up, people at high risk and those with occupational exposure to COVID-19

Fault lines between the FDA and CDC regulatory processes have been on full display in the decisions over which groups of Americans should receive the Pfizer booster shot.

Matthew Woodruff, Instructor of Human Immunology, Emory University • conversation
Sept. 25, 2021 ~6 min


Should fully immunized people wear masks indoors? An infectious disease physician weighs in

As Los Angeles County again mandates masking indoors -- even for the fully vaccinated -- local health officials in the U.S. are closely eyeing their own COVID-19 vaccination and infection rates.

Peter Chin-Hong, Associate Dean for Regional Campuses, University of California, San Francisco • conversation
July 22, 2021 ~9 min

Kids aren't just littler adults – here's why they need their own clinical trials for a COVID-19 vaccine

As many teens and adults in the US restart their social lives, parents of children under the age of 12 wonder when their kids will also be able to experience the freedom that comes with vaccination.

Judy Martin, Professor of Pediatrics, University of Pittsburgh • conversation
July 16, 2021 ~10 min

Should my child get the COVID-19 vaccine? 7 questions answered by a pediatric infectious disease expert

The Pfizer COVID-19 vaccine was recently approved for adolescents ages 12-15. Vaccination is essential to protect children from serious illness and quicken return to normal life.

Debbie-Ann Shirley, Associate Professor of Pediatrics, University of Virginia • conversation
May 14, 2021 ~7 min

How do mRNA vaccines work – and why do you need a second dose? 5 essential reads

So far, most vaccines in the US are mRNA vaccines. These represent a new technology and are likely to take over the vaccine world. But how do they work? What are their weaknesses? Five experts explain.

Daniel Merino, Assistant Editor: Science, Health, Environment; Co-Host: The Conversation Weekly Podcast • conversation
March 16, 2021 ~6 min

3 medical innovations fueled by COVID-19 that will outlast the pandemic

The coronavirus pandemic has driven a lot of scientific progress in the past year. But just as some of the social changes are likely here to stay, so are some medical innovations.

Nevan Krogan, Professor and Director of Quantitative Biosciences Institute & Senior Investigator at the Gladstone Institutes, University of California, San Francisco • conversation
March 9, 2021 ~12 min

How does the Johnson & Johnson vaccine compare to other coronavirus vaccines? 4 questions answered

The Johnson & Johnson vaccine is different from the Moderna and Pfizer vaccines in a few important ways that could make it a huge help to global vaccination efforts.

Maureen Ferran, Associate Professor of Biology, Rochester Institute of Technology • conversation
Feb. 25, 2021 ~7 min


6 important truths about COVID-19 vaccines

With the vaccines now being administered at sites around the US, it is important to address misinformation surrounding the effort.

Kanneboyina Nagaraju, Professor of Pharmacy and Pharmaceutical Sciences, Binghamton University, State University of New York • conversation
Feb. 18, 2021 ~10 min

Will the COVID-19 vaccine work as well in patients with obesity?

Americans with excess weight and obesity have been hit hard by COVID-19. Now there is reason to believe they may not get the same protection from the vaccines.

Cate Varney, Clinical Physician, University of Virginia • conversation
Feb. 8, 2021 ~7 min

/

4